Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Gibertini
Michael Gibertini
Organon International
Major depressive disorder
Tolerability
Psychiatry
Psychology
Nausea
5
Papers
192
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
2009
The Journal of Clinical Psychiatry
Karl Rickels
Maria Athanasiou
Donald S. Robinson
Michael Gibertini
Heidi Whalen
Carol R. Reed
Show All
Source
Cite
Save
Citations (123)
Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
2004
Journal of Psychiatric Research
Jay D. Amsterdam
David J. Brunswick
Michael Gibertini
Show All
Source
Cite
Save
Citations (7)
Gepirone extended-release: New evidence for efficacy in the treatment of major depressive disorder
2003
The Journal of Clinical Psychiatry
Alan D. Feiger
Jon F. Heiser
Ram K. Shrivastava
Kenneth J. Weiss
Ward T. Smith
J. M. A. Sitsen
Michael Gibertini
Show All
Source
Cite
Save
Citations (40)
A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone
2003
Clinical Therapeutics
Donald S. Robinson
J. M. Ad Sitsen
Michael Gibertini
Show All
Source
Cite
Save
Citations (20)
Gepirone extended release (ER): New evidence for efficacy in the treatment of major depressive disorder (MDD)
2002
European Neuropsychopharmacology
Alan D. Feiger
Jon F. Heiser
Ram K. Shrivastava
K. J. Weiss
Ward T. Smith
J. M. A. Sitsen
Michael Gibertini
Show All
Source
Cite
Save
Citations (2)
1